Attending the 7th Central Nervous System Partnering & Deal-Making Conference on September 18-19, Danielle Kerkovich, PhD, traveled to San Francisco. With Beyond Batten Disease Foundation’s focus on partnership and collaboration, this conference was a great opportunity to spread awareness of Batten disease as well as promising BBDF-funded research. Held annually, the conference gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant Central Nervous System disease issues that will affect the industry.
While in San Francisco, Dr. Kerkovich also met with Dione Kobayashi of Audentes Therapeutics. Audentes is a biotechnology company committed to the development and commercialization of innovative new treatments for people with serious, rare diseases, such as juvenile Batten disease. A young start-up, this company is driven by its goal to improve the lives of patients. They, too, want to see life beyond Batten.